Price Chart

Profile

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
URL http://www.neurogene.com
Investor Relations URL N/A
HQ State/Province New York
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 23, 2026 (est.)
Last Earnings Release Nov. 13, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
URL http://www.neurogene.com
Investor Relations URL N/A
HQ State/Province New York
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 23, 2026 (est.)
Last Earnings Release Nov. 13, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A